General Range
Norsunate-200
Price on request/100 · MOQ 100 boxes
Norsunate-200 Tablets by Enormmed Pharma Private Limited contain Artesunate 200 mg, an antimalarial medicine belonging to the artemisinin group. It is used as part of an appropriate combination treatment regimen for malaria caused by susceptible Plasmodium parasites.
Artesunate is a fast-acting antimalarial agent that helps eliminate malaria parasites from the bloodstream. It is converted into its active metabolite, dihydroartemisinin, which acts against the blood stages of malaria parasites and contributes to rapid parasite clearance.
Norsunate-200 Tablets may be prescribed as a component of artemisinin-based combination therapy (ACT) for uncomplicated malaria, particularly Plasmodium falciparum infections. Artesunate must be combined with an appropriate partner antimalarial medicine to improve treatment effectiveness and reduce the development of resistance.
The dosage and duration of treatment depend on the patient's body weight, malaria species, clinical condition and applicable treatment guidelines. Norsunate-200 Tablets should only be used under the supervision of a registered medical practitioner.
CategoryGeneral Range
Min. Order100 boxes
Supplied byEnorm Med Pharma Pvt. Ltd.
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Artesunate Tablets
- Packaging Type
- Tablets
- Packaging Size
- 20 × 1 × 4
- Dosage Form
- Tablet
- Treatment
- Treatment of uncomplicated malaria caused by susceptible Plasmodium parasites when combined with an appropriate antimalarial medicine.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Enorm Med Pharma Pvt. Ltd.Panchkula, Haryana
Enorm Med Pharma Private Limited is an Indian pharmaceutical company based in Panchkula, Haryana, specializing in the manufacture, trade, wholesale, and export of a wide range of pharmaceutical formulations.
Company Overview
• Incorporation / Establishment: Originally started as a proprietorship in 2021, later incorporated as a private limited company on April 9, 2023 (CIN: U46497HR2023PTC110540).
• Registered Address: SCO 272, Sector-20, Panchkula, Haryana – 134116, India.
• Directors / Leadership: Sukhinder Jindal and Gurpreet Jindal.
• Certifications: ISO 9001:2015 and WHO-GMP compliant operations/standards.
• Business Model: PCD (Propaganda Cum Distribution) Pharma Franchise, third-party manufacturing, wholesale distribution, and domestic/global supply.
Product Portfolio
Enorm Med Pharma deals in diverse therapeutic segments and dosage forms, including:
• Dosage Forms: Tablets, capsules, softgelatin capsules, syrups, dry syrups, injections (vials), and ointments.
• Therapeutic Ranges: Anti-infectives, cardiac, diabetic, dermatology, and general wellness/herbal formulas.
• Notable Branded Products: Azeenorm (Azithromycin), Diclonorm, Enomzole-D, Levonorm, Pantenorm, Norsunate (Artesunate injections), and Mebenorm.
More General Range
